France,
July 2010
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and stakeholders crucial insight into a country with a rich tradition in pharmaceuticals and healthcare that is now at the forefront of innovative new trends within these industries
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and stakeholders crucial insight into a country with a rich tradition in pharmaceuticals and healthcare that is now at the forefront of innovative new trends within these industries
